A multiplex PCR technique to characterize human bone marrow derived mesenchymal stem cells.

Area of Science:

• Cell Biology
• Stem Cell Research
• Regenerative Medicine

Background:

• Human mesenchymal stem cells (MSCs) exhibit multipotency, differentiating into various cell types.
• A key question is whether MSC populations are uniform or consist of distinct progenitor subsets.
• Understanding MSC heterogeneity is crucial for developing novel therapeutic applications.

Purpose of the Study:

• To quantify changes in MSC phenotype and differentiation potential during expansion.
• To investigate the correlation between marker expression, proliferation, and differentiation efficiency.
• To assess the reliability of specific markers in defining the 'stem cell' nature of MSCs.

Main Methods:

• Multi-marker RT-PCR using primers for CD73, CD90, CD105, CD166, CD45, and beta-actin.
• Cell proliferation assays performed on MSCs up to the sixth passage.
• Osteogenic and adipogenic differentiation potential verified by culture in inductive media and cytochemical analysis.

Main Results:

• RT-PCR and cytochemical analysis showed a decrease in MSC-specific marker expression during expansion.
• Proliferation ability and differentiation efficiency of MSCs were down-regulated with increasing passage number.
• Certain markers remained expressed despite loss of multipotency, questioning their role as true stem cell indicators.

Conclusions:

• A decrease in MSC-specific marker expression correlates with reduced proliferation and differentiation capacity.
• The observed marker expression patterns suggest limitations in using them to define the true 'stem cell' nature of expanded MSCs.
• Further research is needed to identify reliable markers for MSC populations with consistent therapeutic potential.